Cite

HARVARD Citation

    Ghisoni, E. et al. (2021). Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. European journal of cancer. pp. 153-164. [Online]. 
  
Back to record